Drugs > Bevacizumab News
You are currently reading Bevacizumab news, below you will find the latest Bevacizumab news available at Drug Topics. For more general Bevacizumab information please visit Bevacizumab. Bevacizumab is categorized in the B index of drugs (by medical name) and in A index of drugs (by common name).
We have no matching items at this time. Please check back shortly. |
Health Care's Golden Children (The Motley Fool) The whole industry wasn't down this year. Cancer Medicine Advances on Many Fronts (HealthDay via Yahoo! News) TUESDAY, Dec. 23 (HealthDay News) -- The war against cancer gathered steam in 2008, as new drugs tackled the toughest cancers with some success, and advances were made in both disease prevention and risk factor identification. Kidney cancer patients? families may challenge drug ruling (icWales) FAMILIES denied NHS funding for a life-prolonging cancer drug said last night they are considering a legal challenge against the decisions. Cancer Doctors Fear Chemo Drug Shortage (Forbes) The inability of two drug makers to produce a generic cancer medicine endangers both patients and research. 2008's 12 Major Cancer Advances (WebMD) New or improved treatments for leukemia and for lung, pancreatic, breast, and skin cancers are among ASCO's 12 top clinical cancer advances for 2008. Kidney treatment may by denied due to cost (UPI) CAMBRIDGE, England, Dec. 13 (UPI) -- A British oncologist says he is dismayed that kidney cancer patients may be denied four new treatments due to cost. Roche medicines help women with breast cancer live longer (PharmaBiz) Copyright © Saffron Media Pvt. Ltd. Designed & Maintained by Fast Cursor New Data Evaluating ABRAXANE In Early-Stage Breast Cancer And In Combination With Novel Investigational Agents To Be ... (Medical News Today) Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated, global biotechnology company, today announced that multiple studies of ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin bound) will be presented at the 31st Annual San Antonio Breast Cancer Symposium on December 10-14, 2008. UK kidney cancer patients face toxic, out-dated treatments with little hope of change (News-Medical-Net) Leading oncologist Professor Tim Eisen has expressed concerns that patients with advanced kidney cancer could be condemned to toxic, barely effective, 20 year-old treatments because the National Institute for Health and Clinical Excellence (NICE) is likely to rule out using all four of the new treatments it has assessed. UK kidney cancer patients face toxic, out-dated treatments with little hope of change (EurekAlert!) ( Wiley-Blackwell ) The body that advises the UK Department of Health is likely to rule out four kidney cancer drugs on cost grounds, despite the fact that they represent the biggest breakthrough in treatment of the disease in the last 25 years. Professor Eisen of Cambridge University points out that without them there is no effective treatment for 90 percent of patients with the disease. The ... |
Don't change formula for needed drugs A report from the nation's leading cancer organizations revealed that America's cancer death rate is dropping. FIGHTING: Barbara Moss is leading a campaign to allow patients to buy life-saving drugs. A MOTHER forced to pay for her own cancer care is to write to the Health Secretary as she leads calls for faster access to life-saving drugs for terminally ill patients. A year of the departed They came from every corner of Canada and the world, but 2008 produced a bumper crop of boldface deaths. Nice ruling on drug funding gives hope to cancer patients Expensive drugs to prolong the life of terminally ill cancer patients in England are to be provided free on the NHS , after a change of policy yesterday by the National Institute of Clinical Excellence . Biotech titans fared well Sharp gains in shares of biotechnology heavyweights mitigated the wider sector's decline in 2008. Is overexpression of HER-2 a predictor of prognosis in colorectal cancer? The development of novel chemotherapeutic agents in colorectal cancer has improved survival. Biotech proves defensive against tough 2008 market Sharp gains in shares of biotechnology heavyweights mitigated the wider sector's decline in 2008. Paul Newman, Sir Edmun HIllary and Alexander Solzhenitsyn They came from every corner of Canada and the world, but 2008 produced a bumper crop of boldface deaths. 5 Biotech Stocks To Watch In '09 Where are the healthy bets in this sick economy? Take a peek at biotech stocks. Despite the sectors' reputation for risk and volatility, these days they are acting like safe havens. Worrisome signs loom over 2009 The global equity market is likely to rally in 2009, but the leading question is will this rally be sustainable, asks Stephen Way, senior vice-president at Toronto-based AGF Funds Inc., who specializes in ... |
Drug Topics
Timely and Factual Drug Information and News
Drug Index
If you are researching a particular drug and know its common name use the alphabetical links below to quickly navigate to your desired subject.
If you are researching a particular drug and know its medical name use the alphabetical links below to quickly navigate to your desired subject.
Recommended Drug Sites
The following drug sites are listed in alphabetical order.
Recommended Health Sites
The following health sites are listed in alphabetical order.
- Anti-Aging Revolution
- Hormone Health
- Medaus Compounding Center
- Personal Trainer Search
- Womens Health Concerns
Bookmark Us
The On Topic Network
This website is part of The On Topic Network.
Thank You
Drug-Topics.org was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.